Guangdong Taienkang Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Guangdong Taienkang Pharmaceutical has a total shareholder equity of CN¥1.8B and total debt of CN¥255.9M, which brings its debt-to-equity ratio to 14%. Its total assets and total liabilities are CN¥2.3B and CN¥461.1M respectively. Guangdong Taienkang Pharmaceutical's EBIT is CN¥167.3M making its interest coverage ratio -30. It has cash and short-term investments of CN¥589.4M.
Belangrijke informatie
14.0%
Verhouding schuld/eigen vermogen
CN¥255.86m
Schuld
| Rente dekkingsratio | -30x |
| Contant | CN¥589.40m |
| Aandelen | CN¥1.82b |
| Totaal verplichtingen | CN¥461.08m |
| Totaal activa | CN¥2.29b |
Recente financiële gezondheidsupdates
Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Can Manage Its Debt Responsibly
Jul 22
Guangdong Taienkang Pharmaceutical (SZSE:301263) Seems To Use Debt Quite Sensibly
Feb 26Recent updates
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)
Sep 03Guangdong Taienkang Pharmaceutical Co., Ltd.'s (SZSE:301263) P/E Still Appears To Be Reasonable
Aug 23Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Can Manage Its Debt Responsibly
Jul 22Guangdong Taienkang Pharmaceutical (SZSE:301263) Is Paying Out Less In Dividends Than Last Year
May 22Guangdong Taienkang Pharmaceutical (SZSE:301263) Seems To Use Debt Quite Sensibly
Feb 26Analyse van de financiële positie
Kortlopende schulden: 301263's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥340.7M).
Langlopende schulden: 301263's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥120.4M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 301263 has more cash than its total debt.
Schuld verminderen: 301263's debt to equity ratio has increased from 6.4% to 14% over the past 5 years.
Schuldendekking: 301263's debt is not well covered by operating cash flow (10.9%).
Rentedekking: 301263 earns more interest than it pays, so coverage of interest payments is not a concern.